Cargando…

Toxicity and Efficacy After Adjuvant Vaginal Brachytherapy Using 30 Gy in 6 Fractions for Stages I and II Endometrial Cancer

PURPOSE: This study aimed to evaluate outcomes and toxicity in patients with endometrial cancer per our institutional adjuvant vaginal cuff brachytherapy (VBT) fractionation scheme. METHODS AND MATERIALS: We identified women with International Federation of Gynecology and Oncology stages I and II en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arden, Jessica D., Dokter, Jonathan, Almahariq, Muayad F., Marvin, Kimberly, Nandalur, Sirisha R., Al-Wahab, Zaid, Gadzinski, Jill, Rosen, Barry, Jawad, Maha Saada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655421/ https://www.ncbi.nlm.nih.gov/pubmed/34934859 http://dx.doi.org/10.1016/j.adro.2021.100773

Ejemplares similares

Outcomes After Salvage Radiation Therapy for Recurrent Endometrial Cancer in Patients With No Prior Adjuvant Therapy: An Institutional Review
por: Arden, Jessica D., et al.
Publicado: (2020)

Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer
por: Arden, Jessica D., et al.
Publicado: (2020)

Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2012)

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
por: Eldredge-Hindy, Harriet Belding, et al.
Publicado: (2014)

Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients – in view of the recent evidence
por: Serkies, Krystyna, et al.
Publicado: (2021)

Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer
por: Gultekin, Melis, et al.
Publicado: (2020)

Brachytherapy in a Single Dose of 10Gy as an “in situ” Vaccination
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2020)

Vaginal cuff dehiscence after intracavitary brachytherapy for endometrial cancer
por: Albuquerque, Kevin, et al.
Publicado: (2012)

Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?
por: Sabater, Sebastià, et al.
Publicado: (2017)

Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy
por: Ozdemir, Yurday, et al.
Publicado: (2017)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma
por: Zhang, Yaowen, et al.
Publicado: (2020)

Dosimetric evaluation of vaginal cuff brachytherapy planning in cervical and endometrial cancer patients
por: Sikorska, Katarzyna, et al.
Publicado: (2020)

Preliminary clinical outcomes of patients treated with vaginal brachytherapy alone using multi-channel vaginal brachytherapy applicator in operated early-stage endometrial cancer
por: Rishi, Karthik S., et al.
Publicado: (2021)

Acute and late toxicities in localized prostate cancer patients treated with low-dose (125)I brachytherapy (110 Gy) in combination with external beam radiation therapy versus brachytherapy alone (160 Gy)
por: Mukai, Yuki, et al.
Publicado: (2018)

Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial Cancer
por: Cisek, Paweł, et al.
Publicado: (2018)

Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
por: Laliscia, Concetta, et al.
Publicado: (2016)

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
por: Facondo, Giuseppe, et al.
Publicado: (2022)

The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer
por: Huddleston, Adam, et al.
Publicado: (2015)

Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer
por: Guler, Ozan C., et al.
Publicado: (2014)

Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer
por: Qian, Jack M., et al.
Publicado: (2017)

The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review
por: Lancellotta, Valentina, et al.
Publicado: (2020)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2012)

Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer
por: Kim, Donghyun, et al.
Publicado: (2018)

Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer
por: Akiyama, Hironori, et al.
Publicado: (2012)

Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction((α/β=3Gy)) at 2 cm(3) of vagina
por: Aguilera, María del Valle, et al.
Publicado: (2018)

Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology Group
por: Bolukbasi, Yasemin, et al.
Publicado: (2021)

Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer
por: Sapienza, Lucas Gomes, et al.
Publicado: (2015)

Dosimetric impact of cylinder size in high‐dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer
por: Zhang, Hualin, et al.
Publicado: (2016)

Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis
por: Zhang, Y., et al.
Publicado: (2021)

Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results
por: Latorre, Javier Anchuelo, et al.
Publicado: (2018)

Dosimetric impact of bladder filling on organs at risk with barium contrast in the small bowel for adjuvant vaginal cuff brachytherapy
por: Buzón, María del Carmen Salas, et al.
Publicado: (2021)

Reliability of algebraic sum to evaluate adjuvant pelvic radiotherapy and vaginal cuff brachytherapy cumulative doses in uterine cancers
por: Casale, Michelina, et al.
Publicado: (2022)

Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer
por: Sekii, Shuhei, et al.
Publicado: (2017)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Pregnancy after sugery and brachytherapy for vaginal cancer
por: Gerbasi, Giovana Junqueira, et al.
Publicado: (2023)

Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: toxicity, prostate-specific antigen kinetics, and cancer control
por: Mayrata, Esther, et al.
Publicado: (2021)

Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study
por: Dooley, William C, et al.
Publicado: (2010)

Adjuvant brachytherapy for Stage IB Grade 2 endometrial carcinoma: Multivariate analysis of a single institution experience
por: Tokar, Margarita, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0o59mhtqdbsvd44g41a7bo5ie3